MDT - Company ID 0001613103
The table below shows Medtronic plc's income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Revenue | $36.36B | $33.54B | $32.36B | $31.23B | $31.69B | $30.12B |
| Cost of revenue | $12.72B | $11.63B | $11.22B | $10.72B | $10.14B | $10.48B |
| Gross profit | - | - | - | - | - | - |
| R&D | - | - | - | - | - | - |
| SG&A |
Medtronic plc reported annual revenue of $36.36B for fiscal year 2026. That is up 8.4% from $33.54B in fiscal 2025. Over the 10 fiscal years shown, annual revenue grew from $29.71B (FY 2017) to $36.36B. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $11.78B |
| $10.85B |
| $10.74B |
| $10.41B |
| $10.29B |
| $10.15B |
| Operating income | $6.47B | $5.96B | $5.14B | $5.49B | $5.75B | $4.48B |
| Income tax | $1.30B | $936.00M | $1.13B | $1.58B | $456.00M | $265.00M |
| Net income | $4.80B | $4.66B | $3.68B | $3.76B | $5.04B | $3.61B |
| EPS (diluted) | $3.73 | $3.61 | $2.76 | $2.82 | $3.73 | $2.66 |